Compare SPB & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPB | AMPH |
|---|---|---|
| Founded | 1906 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 2014 |
| Metric | SPB | AMPH |
|---|---|---|
| Price | $59.78 | $26.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $83.50 | $31.00 |
| AVG Volume (30 Days) | 286.8K | ★ 389.3K |
| Earning Date | 02-05-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.86 | 2.27 |
| Revenue | ★ $2,809,000,000.00 | $723,305,000.00 |
| Revenue This Year | $1.64 | $1.35 |
| Revenue Next Year | $1.47 | $5.10 |
| P/E Ratio | $15.54 | ★ $11.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $49.99 | $20.39 |
| 52 Week High | $87.23 | $39.56 |
| Indicator | SPB | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 53.61 |
| Support Level | $59.01 | $26.26 |
| Resistance Level | $60.81 | $27.44 |
| Average True Range (ATR) | 1.81 | 0.83 |
| MACD | -0.18 | 0.04 |
| Stochastic Oscillator | 54.39 | 71.43 |
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.